Takeda Pharmaceutical Company Limited has grown revenue 8.7% a year over three years and 6.8% a year over five, with earnings per share compounding at −23%. Revenue growth, 3-year annual rate: +8.7% (Drug Manufacturers - Specialty & Generic median +15%). Revenue growth, 5-year rate: +6.8%, growth has picked up over the last three years. Earnings per share, 3-year rate: −23%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 9, FY2017 to FY2025, as filed.

TAKTakeda Pharmaceutical Company Limited

HealthcareUSD

$18.25

$13.2352 weeks$18.80

Is it growing?

Is TAK growing?

Takeda Pharmaceutical Company Limited has grown revenue 8.7% a year over three years and 6.8% a year over five, with earnings per share compounding at −23%.

+8.7%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +15% · steady growth, ahead of inflation · compounded from fiscal years as filed

Revenue growth, 5-year rate: +6.8%
Revenue growth, 5-year rate · +8.7% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: −23%
Earnings per share, 3-year rate · revenue +8.7% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 9
Years of annual history on file · FY2017 to FY2025, as filed